Medical
Medical LED Light Sources
PRP Optoelectronics are a company specialising in the design and manufacture
of custom LED arrays. The company has been involved in the use of LED arrays
in Photodynamic Therapy since 1993 with our light sources being used in
a number of pre-clinical and clinical trials.
Our devices have been successfully used in the treatment of skin cancers,
acne and cosmetic therapies.
All systems are designed and manufactured in our EN 46002 certified facility.
Intense light sources have a number of potential applications in medical
treatment. Among these is Photodynamic Therapy (PDT), a process that can
be used for the selective destruction of cells without harming adjacent
tissue. The technique uses special photosensitising agents which when irradiated
with light at a specific wavelength, react with oxygen in tissues to bring
about cell death. The treatment has been applied to a number of malignant
and benign skin disorders. Laser sources have been used in PDT, but have
disadvantages in cost and also because special precautions have to be taken
in their use. Specially designed LED sources can be used in PDT and have
advantages in that they are intrinsically less dangerous in use and can
be employed in clinics with out the need for special precautions.
PRP Optoelectronics were involved in the use of LED arrays in Photodynamic
Therapy as early as 1993 with our LED light sources being used in a number
of pre-clinical and clinical trials, in a number of sites, including The
Royal London Hospital, the Amsterdam Cancer Institute and University College
Hospital. Light sources were developed with outputs designed for use with
wavelengths matching absorption spectra of specific photosensitisers with
the LED outputs centred around at 630nm, 652nm and 690nm. With careful
thermal design PRP showed that it was possible to achieve output intensities
higher than 200mW/cm2 uniformly over areas as large as 16cm2. Following
successful clinical trials in conjunction with medical teams, PRP designed
produced and sold the PRP100 (shown above) for use in hospitals and dermatology
clinics. Other products have been designed and supplied for clinical trials
with other photosensitisers.
PRP 100 PDT Light Source

The source area, 16 square cm (sq.cm), allows large lesions to be treated,
while the square shape makes easier the sequential treatment of even larger
areas. The LEDs in the array are selected to provide an output spectrum
matching that of protoporphyrin IX, the endogenous photosensitiser produced
by the application of ALA. A power output of up to 2.5 Watts allows intensities
up to 150 mW/sq.cm at 630nm to be achieved over the treatment area with
uniformity better than ± 10%. In use, the LED source, covered by
a disposable protective shield, is placed in contact with the skin to define
the treated area. Although the LED light source is very bright, it does
not produce a coherent beam and there is no danger of retinal damage. The
array is attached to the cooling system and control unit by a flexible
cord, and the whole system can be mounted on a trolley or desk top.
For further information or to request a demonstration, please contact
Dr. Peter Hart or Dr. Geoff Lidgard at PRP Optoelectronics:
Tel: +44 (0) 1327 359135
PRP 100 Features
- Convenient and easy to use
- Output spectrum matches popular photosensitisers
- Intensity levels up to 150 mW/sq.cm @ 630nm
- Treatment area up to 16 sq.cm at full power
- No unwanted broadband light or heat emissions
- No need for safety goggles or door locks
- Ergonomic, compact and portable
- Low total cost of ownership (TCO)
- Meets international safety standards
- Alternate wavelengths and outputs available